Search results
Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024
BioPharma-Reporter· 10 hours agoBPR: What new products or innovations is your company showcasing at BIO 2024 this year? This year we...
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 6 days agoCrinetics Pharmaceuticals (CRNX) delivered earnings and revenue surprises of -10.71% and 21.47%,...
Earnings call: Cipher Pharmaceuticals reports strong Q1 with revenue up 20% By Investing.com
Investing.com· 5 days agoCipher Pharmaceuticals (OTC:CPHRF) Inc. (TSX:CPH) has released its Q1 2024 financial results,...
Q1 2024 Arcutis Biotherapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 hours agoThese efforts also lay a solid foundation for the brand and the building of a portfolio. Anyone search changes and deductible resets typically create a dip in prescription trends in the first ...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 6 days agoAll told, AT&T is exhibiting a healthy downward trend in customer churn, making strides in reducing debt, and investing in infrastructure that promises...
Novartis to showcase next-gen manufacturing solutions at BIO 2024
BioPharma-Reporter· 10 hours agoAt BIO 2024, Novartis Contract Manufacturing will actively demonstrate its commitment to supporting...
Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
Zacks· 3 days agoFree Report) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.21. This quarterly report represents an earnings surprise of -19.05%. A quarter ...
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Zacks· 2 days agoThe Zacks Large Cap Pharmaceuticals industry, to which AbbVie belongs, has gained 4.4% over this period. Now the key question is: Where could...Although ...
Behind the Scenes of Annovis Bio's Latest Options Trends - Annovis Bio (NYSE:ANVS)
Benzinga· 2 hours agoWhat The Experts Say On Annovis Bio Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $26.333333333333332 ...
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript May 8, 2024 Amphastar...
